Managing Hyperphosphatemia in Patients on Hemodialysis: A Comparison of Sucroferric Oxyhydroxide (SO) Monotherapy and Tenapanor with Other Non-SO Phosphate Binders

Authors: Meijiao Zhou, Linda Ficociello, Hao Han, Michael S. Anger

Published: 2024-10-28

DOI: 10.1681/asn.2024v5zat6ve

Keywords: No keywords found.

Abstract:
No abstract found.

Source: